Related Experiment Videos
Molecular aspects of scleroderma
1Division of Rheumatology and Immunology, Medical University of South Carolina, 96 Jonathan Lucas St., Suite 912, Charleston, SC 29425, USA. trojanme@musc.edu
Abstract:
Scleroderma is a complex disease characterized by activation of the immune system, small-vessel vasculopathy, and fibrosis of the skin and other organs. This review is limited to the discussion of scleroderma fibroblast biology and the cellular and molecular mechanisms that contribute to the abnormal deposition of collagen. Selected aspects of abnormal extracellular matrix (ECM) regulation by scleroderma fibroblasts are critically reviewed. These include the role of transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) and their receptors in the fibrotic process in scleroderma and the overview of the transcription factors involved in regulation of the human alpha2 (I) collagen (COL1A2) gene.
Insights
Scleroderma involves immune activation and fibrosis. This review focuses on scleroderma fibroblast biology, exploring how transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) drive abnormal collagen deposition.
Area of Science:
- Fibrosis research
- Connective tissue disorders
- Immunodermatology
Background:
- Scleroderma is a complex autoimmune disease.
- Characterized by immune system activation, vasculopathy, and fibrosis.
- Fibrosis involves abnormal extracellular matrix (ECM) deposition.
Purpose of the Study:
- To review scleroderma fibroblast biology.
- To examine cellular and molecular mechanisms of abnormal collagen deposition.
- To discuss ECM regulation in scleroderma.
Main Methods:
- Literature review focusing on fibroblast biology.
- Analysis of molecular mechanisms in fibrosis.
- Examination of growth factors and transcription factors.
Main Results:
- Scleroderma fibroblasts exhibit abnormal ECM regulation.
- Transforming growth factor-beta (TGF-beta) and connective tissue growth factor (CTGF) play key roles.
- Transcription factors regulate collagen gene expression (COL1A2).
Conclusions:
- Scleroderma fibroblast biology is central to disease pathogenesis.
- TGF-beta and CTGF are critical mediators of fibrosis.
- Understanding these mechanisms may lead to targeted therapies.